Discovery and development of biomarkers and elucidation of the mechanism underlying BM in NSCLC is critical for effective prophylactic interventions. However, the exact parts played by miR-330-3p in BM of NSCLC remain unknown.
Recent studies demonstrated that microRNA-330-3p (miR-330-3p) was involved in NSCLC brain metastasis (BM).
Brain metastasis (BM) is associated with poor prognosis in patients with non-small cell lung cancer (NSCLC).
